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http:WHAT THIS PAPER ADDS
Loss of arterial compliance is an important cardiovascular risk factor. Compliance decreases with age, hyper-
tension, and menopause, and its reduction is associated with endothelial dysfunction and adverse cardiovas-
cular events. Pathological loss of compliance is, usually, an insidious process. However, endograft placement
results in a more acute drop in compliance, which not only effects cardiovascular risk, but, also, through the ﬂuid
structure interactions may inﬂuence stent graft durability and the development of complications. The variation
in compliance between commercially available stent grafts was investigated to examine which devices have the
least adverse effect on aortic compliance.Objective/background: To investigate experimentally the arterial wall/device compliance mismatch of four stent-
graft devices and a multilayer ﬂow modulator within the supra- and infrarenal locations for the treatment of
abdominal aortic aneurysms (AAA).
Methods: Five devices (MFM, EndurantII, Excluder, Zenith, and Fortron) were tested under physiological ﬂow
conditions within a ﬂow simulator system comprising of a patient-speciﬁc thin-walled ﬂexible AAA perfusion
model with replicated intraluminal thrombus, supported by the spinal column. Devices were submitted to
circumferential force tests and implanted in the perfusion model for circumferential arterial pressure/diameter
measurements. Parameters, including radial resistive force, supra-/infrarenal compliance, pulsatile arterial energy
loss (PAEL), pulse wave velocity (PWV), and wave reﬂection coefﬁcient (G), were computed to characterise the
devices’ performance.
Results: The Zenith and EndurantII devices had the highest radial resistive force (up to 3 N/cm), while the Fortron
device had the lowest (0.11 N/cm). Supra- and infrarenal compliance varied between 6.9e5.1  104/mmHg and
4.8e5.4  104/mmHg, respectively. Two devices (EndurantII and Excluder) signiﬁcantly decreased infrarenal
compliance by 13e26% (p < .001). Four devices increased the PAEL by 13e44% (p < .006). The PWV ranged
from 10.9 m/s (MFM; p ¼ .164) to 15.1 m/s (EndurantII; p < .001). There was an increase of 8e238% (p < .001)
in the reﬂection coefﬁcient for all devices.
Conclusion: Commercially available endovascular devices lower the aortic wall compliance after implantation.
The MFM was found to be the most compliant in the suprarenal region, while the Fortron device was the most
compliant in the infrarenal region. Choosing the most compliant devices for treating AAAs produces positive
gains in the aortic elastic recoil, thus minimising the device related complications.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Endovascular aneurysm repair (EVAR) is the contemporary
ﬁrst-line therapy for abdominal aortic aneurysms (AAA),
with open repair reserved for those who are unﬁt for EVAR.
EVAR offers clear beneﬁts when compared with open repair,
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 45in terms of less trauma, short hospital stay, reduced mor-
tality, and lower morbidity. However, associated device
ﬁxation problems, such as endoleaks, migration, and prox-
imal neck enlargement,1,2 can affect the long-term success.3
Radial arterial wall compliance (C) is a change in vessel
diameter or cross-sectional area triggered by a change in
blood pressure. C, relative pulsatility, and pulsatile diameter
are dramatically changed following the arterial device im-
plantation.4,5 The changes in compliance at the interface
stent/arterial wall, represent a result of the device-to-
arterial wall mechanical coupling. To date, it is unclear
how stents affect the compliance of an artery, as compli-
ance varies from one type of stent to another. One stent
type can cause the arterial wall to behave rigidly, while
another type may have no effect.6
The reduction in C inﬂuences the haemodynamics in
terms of blood ﬂow patterns and von Mises stress in the
wall,7 as was shown by Ene et al.,8 who computationally
analysed six AAAs under different assumptions, such as
static/transient pressures, steady/transient ﬂows, and
rigid/compliant walls. Vernhet et al. and Morris et al.
showed a signiﬁcant decrease in compliance when using
small stents in small-calibre rabbit arteries and a stent-
graft (SG) device within an AAA perfusion model, respec-
tively,2,7 while Pihkala et al. found that implanted stents in
pig aortas did not affect C or alter the pulse wave velocity
(PWV).9 Also, in vivo monitoring by intravascular ultra-
sound within coronary lesions shows a decrease in
compliance after the implantation of endovascular scaf-
folds.10 Changes in C trigger arterial dysfunction and
pathophysiology, which have a key role in vascular
biomechanics and homeostasis.11 Vlachopoulos et al.
found that a 1 m/s increase in the PWV generates a 14%
increased risk of cardiovascular events, cardiovascular
mortality, and all-cause mortality.12
It was hypothesised, in this study, that SG devices play a
major role in altering the local C after implantation. To test
the hypothesis four SGs: EndurantII (Medtronic, Dublin
Ireland), Fortron (Cordis, Sommerville, NJ, USA), Zenith
(Cook Medical, Bloomington, IN, USA), Excluder (Gore
Medical, Putzbrunn, Germany) and one Multilayer Flow
Modulator (MFM) device (Cardiatis, Isnes, Belgium) were
deployed in an AAA perfusion model.
METHODS
SG and MFM devices
Four bifurcated SG devices and the MFM device were
dynamically tested within the AAA perfusion model
(Fig. 1A).
All SGs have a thin-walled graft covering the aneurysmal
sac region (Fig. 1A), while the MFM has no graft. The MFM
device is also bifurcated by stapling at the bottom half by
the manufacturer, thus creating two tubular channels in
which two smaller MFM stents are ﬁtted as device limbs.
Table 1 summarises the devices sizes according to in-
structions for use (IFU). Based on the infrarenal internal/
external neck sizes of the AAA, the clinicians sized thedevices according to the manufacturers’ IFU. The maximum
proximal and distal diameters varied from 28e30 mm and
14e16 mm, respectively. The devices were deployed inside
the perfusion model, as shown in Fig. 2(A, B), and outer
neck diameters were measured at rest without any pres-
surisation, as shown in Table 2, in order to ensure that the
experiment started at similar levels of neck dilatation.Circumferential force test rig setup
The chronic outward force (COF) is a measure of the force
the stent exerts on the artery as it tries to expand to its
nominal diameter during vessel expansion. The radial
resistive force (RRF) is a measure of the force the stent
exerts, as it resists circumferential compression by
constriction of the artery. Both parameters depend on the
state of compression. The terms COF and RRF were coined
by Duerig et al. to better describe the circumferential forces
of self-expanding stents.13
COF and RRF were measured with the use of a high-
strength, low-friction, 10-mm wide and 0.2-mm thick
double-strip material (Tyvek paper with polyester/poly-
ethylene laminated ﬁlm; DuPont,Wilmington, DE, USA) that
was looped around the proximal end of the devices, and
threaded through a narrow gap between two rollers of the
circumferential force test rig (Fig. 1B), similar to the tests
conducted by Duda et al.14 One end of the strip was
attached to a ﬁxed base, while the other end was attached
to the clamp of a tensile tester machine (Instron 5544;
Instron, High Wycombe, UK), equipped with 10N static
load cell.
The devices were mounted on a horizontal bar support,
aligned with the material loop, in order to maintain their
position during testing (Fig. 1C). There were 10 samples
(cycles) per test, done for each SG, at an extension rate of
190 mm/min. The test was repeated 10 times for each
device. All devices were compressed circumferentially, by a
maximum of 20% reduction in the circumferential length.
The reduction in diameter was given by the following for-
mula:
Diameter ratio ¼ 1 Cd
pD
(1)
where
Cd is the circumferential displacement, D is the maximum
proximal diameter of the device.
To ensure full stent expansion before testing devices
were preheated in an oven at 45 C for 10 min. The test
started with the SGs expanded to the maximum proximal
diameter state. All devices were crimped to 80% of the
initial diameter and then unloaded to the nominal outer
diameter, forming a cycle or a hysteresis describing the
mechanical behaviour of the materials, as shown in Fig. 3.Patient-speciﬁc AAA perfusion model fabrication
A patient-speciﬁc thin-walled ﬂexible AAA perfusion model
with intraluminal thrombus (ILT), and the inclusion of renal
Table 1. Characteristics of the ﬁve endovascular abdominal aortic aneursym devices.
Device features MFM EndurantII Excluder Zenith Fortron
Intended for use aortic vessel
diameter (mm)
24e28 23e25 24e26 23e24 23e27
Maximum proximal diameter (mm) 30.0 28.0 28.5 28.0 30.0
Maximum distal diameter (mm) 16.0 16.0 14.5 14.0 16.0
Device length (mm) 150 170 160 184 200
% Degree of oversizing (IFU) 25.0 17.0 18.8 17.0 25.0
Uncovered ﬁxation length (mm) e 15 0 30 30
Fixation type Radial force Radial force, barbs Radial force, barbs Radial force, barbs Radial force, barbs
Proximal ﬁxation location Suprarenal Renal Infrarenal Suprarenal Suprarenal
Stent material Cobalt alloy Nitinol Nitinol Stainless steel Nitinol
Fabric material e Woven polyester ePTFE Woven polyester Woven polyester
Measured wall thickness (mm) 0.7 0.5 0.4 0.4 0.5
Activation type Self-expanding Self-expanding Self-expanding Self-expanding Self-expanding
Activation temperature (C) e >30 >30 e >30
Note. IFU ¼ instructions for use; ePTFE ¼ expanded polytetraﬂuoroethylene.
Figure 1. Endovascular devices and circumferential force test rig set-up. (A) Tested commercially available endovascular devices. (B) Test rig
for chronic outward and radial resistive circumferential force measurements, mounted on the tensile tester machine (Instron 5544). (C)
Endovascular devices mounted on the circumferential force test rig. Note. SG ¼ stent-graft.
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Figure 2. Patient-speciﬁc abdominal aortic aneurysm (AAA) silicone perfusion model mounted on a spinal column and ﬂow simulator set-
up. (A) Anterior view; (B) right view; (C) the schematic and components of the AAA ﬂow simulator; (D) suprarenal ﬂowrate waveform; (E)
suprarenal pressure waveform; (F) comparison of suprarenal pressureechange in diameter (PeDD) curve of the AAA silicone perfusion
model with the PeDD curve for older patients with AAAs (Sonesson et al.)20; (G) suprarenal section 30 mm above the renal branching area;
(H) infrarenal section 30 mm below the renal branching area; (I) suprarenal PeDD curve; (J) infrarenal PeDD curve.
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 47and common iliac arteries, was fabricated from translucent
silicone elastomers by the injection moulding technique as
previously described for idealised cases (Fig. 2A, B).15,16 This
perfusion model was based on a 72-year-old patient, with
the three-dimensional (3D) geometry segmented within the
commercially available image reconstruction software
package Mimics 16.0 (Materialise, Leuven, Belgium). The
AAA had a conical-shaped proximal neck with constant in-
ternal diameters of 23 mm (cranial) and 27 mm (caudal) onoverall circumferences, neck length of 48 mm, and
infrarenal neck angulation of 57.
The maximum aneurysm outer diameter was 65 mm, iliac
bifurcation inner diameter was 33 mm, and the left/right
common iliac inner diameters were 13 mm. The arterial wall
was replicated by Elastosil 4641 silicone (Wacker Chemie
AG, Munich, Germany) with 5% silicone ﬂuid (Dow Corning,
UK) by weight and the ILT was replicated by Elastosil 4600
(Wacker Chemie AG, Germany) silicone with 25% silicone
Table 2. Outer diameter of the perfusion model infrarenal neck after device implantation at rest, without pressurisation; chronic outward and radial resistive force measurements, and
calculated circumferential loading/unloading cycle energy loss at the infrarenal region; perfusion model abdominal aortic aneurysm (AAA) compliance; pulse wave velocity (PWV);
reﬂection coefﬁcient (G); and pulsatile arterial energy loss (PAEL) parameter comparisons for unstented/stented sections within the supra/infrarenal perfusion model’s regions, at the
95% ManneWhitney conﬁdence interval (CI).
Device Neck outer diameter after
device implantation (mm)
Chronic outward
force (N/cm)
Radial resistive
force (N/cm)
Energy loss (hysteresis)
(mm/mmHg)
PAEL
Median (IQR)
(mm/mmHg)
CI (% variation)a p
Unstented 28.00 NA NA NA 2.3 (2.1e2.5) NA NA
MFM 28.14 0.06 0.84 0.03 3.3 (3.0e3.4) (48.5e33.3) <.001
EndurantII 28.63 0.54 2.85 0.15 2.3 (2.0e2.5) (e9.4 to 7.6) .903
Excluder 28.49 0.34 1.70 0.05 2.3 (2.0e2.4) (54.7e40.5) <.001
Zenith 28.31 0.67 2.88 0.14 2.7 (2.6e2.9) (27.1e10.2) <.001
Fortron 28.24 0.03 0.11 0.01 2.6 (2.3e2.9) (23.1e3.6) .006
Perfusion AAA model wall compliance PWV G
Suprarenal Infrarenal
Median (IQR)
(10e4/mmHg)
CI (% variation)a p Median (IQR)
(104/mmHg)
CI (% variation)a p Median
(IQR) (m/s)
CI
(% variation)a
p Median (IQR) (%) CI
(% variation)a
p
Unstented 7.1 (6.9e7.6) NA NA 5.4 (5.2e5.7) NA NA 10.6 (10.4e11.0) NA NA 7.6 (7.4e7.8) NA NA
EndurantII 5.1 (5.0e6.1) (e16.4 to 27.9) <.001 4.8 (4.2e5.0) (e12.4 to 22.4) <.001 15.1 (14.2e15.2) (43.5e39.5) <.001 23.7 (23.4e24.0) (212.6e207.8) <.001
MFM 6.4 (5.8e7.3) (e5.0 to 17.8) .002 5.4 (4.8e6.2) (e7.4 to þ8.8) .925 10.9 (10.5e11.0) (e3.4 to 0.4) .164 8.2 (8.0e8.4) (11.0e5.7) <.001
Excluder 6.9 (6.2e7.7) (e8.8 to 3.8) .675 4.9 (4.4e4.9) (e9.7 to 17.5) <.001 14.9 (14.6e15.0) (41.4e37.4) <.001 23.2 (22.9e23.5) (206.4e201.2) <.001
Zenith 6.0 (5.7e6.7) (e10.0 to 19.2) <.001 5.3 (4.4e5.8) (e2.6 to 14.0) .262 11.1 (10.9e11.4) (6.5e2.7) <.001 8.9 (8.8e9.3) (20.9e15.8) <.001
Fortron 6.1 (5.7e6.8) (e8.4 to 18.5) <.001 5.2 (5.0e5.6) (e0.15 to þ8.3) .057 10.8 (10.6e11.1) (3.8e0.3) .036 8.6 (8.3e8.8) (15.5e11.0) <.001
Note. IQR ¼ interquartile range; NA ¼ not applicable.
a A negative sign refers to a percentage decrease; other values refer to percentage increase.
48
L.
M
o
rris
et
al.
Figure 3. Deformation characteristics of all ﬁve devices during the circumferential loading (radial resistive) and unloading (chronic outward)
cycles.
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 49ﬂuid (Dow Corning, Barry, UK) by weight. Owing to poor
resolution of the computed tomography images the aortic
wall thickness could not be measured and reconstructed.
Therefore, the aortic wall thickness was assumed to be
constant at 2 mm. The Young’s Modulus for the silicone wall
and ILT was 1.2 and 0.2 MPa, respectively, as tested on a
uniaxial tensile testing machine (Instron 5544). These elastic
properties were within previously reported tensile testing
values for the abdominal aortic wall (1e6 MPa)17 and ILT
(0.05e0.27 MPa)18 tissues. The spinal column model(Fig. 2A, B) was rapid prototyped by a 3D printer (Stratasys
Prodigy Plus; Stratasys, Eden Prairie, MN, USA) and sup-
ported the AAA model.Flow simulator system
Blood was replicated with 56% deionised water and 44%
glycerine (Univar Ltd,West Yorkshire, UK) that had a dynamic
viscosity of 0.0035 Pa∙s at 37 C, as found from a digital cone
and plate viscometer (DV-II þPRO; Brookﬁeld Engineering,
Figure 4. Pressureechange in diameter (PeDD) curves for the stented abdominal aortic aneurysm perfusion model at the suprarenal
region (section 1) and box and whiskers plot of the arterial wall compliance. The centre line of the box denotes the median value, the
extremes of the box represent the interquartile range, and the whiskers refer to the maximum and minimum data range.
50 L. Morris et al.Brookﬁeld,WN, USA) and a density of 1,055 kg/m3 found by a
50-mL burette and weighing scales. The required tempera-
ture of 37 C was controlled by a heating unit (Julabo Ltd,
Peterborough, UK), with constant ﬂuid stirring.
A custom-built ﬂow simulator replicated the aortic ﬂow-
rate and pressure waveforms (Fig. 2CeE)19 by a program-
mable linear actuator (Aerotech, Wythenshawe, UK). An
ultrasonic ﬂow meter (TS410 plug-in module; Transonic,
Ithaca, NY, US) and ﬂowsensor (25PXN Inline ﬂow sensor;
Transonic) recorded the ﬂowrates. Twenty-two and 28% ofthe inlet ﬂowrate travelled through each renal and common
iliac arteries, respectively.19 A distal compliance chamber and
outlet valves controlled the pressure within physiological
limits (Fig. 2C). The pressure waveform was recorded using a
3F pressure catheter (Scisense Inc., London, ON, Canada),
positioned at the current site of measurement, along the
imaginary centreline of each device. The average difference
between the supracoeliac input (230 mL/s) and measured
peak ﬂowrate (220.8 mL/s), pressure (input 119 mmHg;
output 114 mmHg) were <5%, as shown in Fig. 2(D, E).
Figure 5. Pressureechange in diameter (PeDD) curves for the stented abdominal aortic aneurysm perfusion model at the infrarenal region
(section 2) and box and whiskers plot of the arterial wall compliance. The centre line of the box denotes the median value, the extremes of
the box represent the interquartile range, and the whiskers refer to the maximum and minimum data range.
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 51The change in diameter (DD) was measured by a 4-mega
pixel charge-coupled device camera (Dalsa 4M30; Dalsa
Corp., Waterloo, ON, Canada) with attached Schneider
Enlarger lens (aperture F 2.8) and a frame rate of 30
frames/s. An automatic edge detection tool (IMAQ soft-
ware; National Instruments, Newbury, UK) identiﬁed the
outer edges of the perfusion model. The DPeDD curve
found by Sonesson et al. describing the infrarenal stiffness
behaviour of the arterial wall in a 69-year-old age group wasused to validate the reproducibility of the human aortic wall
behaviour within the perfusion model (Fig. 2F).20 Pressure
and change in diameter (DPeDD) measurements were
taken at the suprarenal and infrarenal locations, 30 mm
above and below the renal arteries, prior to stenting
(Fig. 2G, H). The DPeDD supra- and infrarenal curves for the
perfusion model are shown in Fig. 2 (I, J).
There was very good agreement between the replicated
perfusion model’s behaviour with the in vivo AAAs.
52 L. Morris et al.The C of the unstented and stented perfusion models
were calculated by the following formula21:
C ¼ 1
Asys
$
ðAsys  AdiasÞ
ðPsys  PdiasÞ (2)
Where the pressure (P) and area (A) were based on the
systole and diastole values of the cardiac cycle. The perfu-
sion model had a median compliance variation of 5.4e
7.1  104/mmHg. These results agreed with the nonin-
vasive ultrasonic C measurements for the native aorta
found by Vorp et al. (5.1e19.0  104/mmHg).21
All statistical comparisons were generated within Minitab
16.2.0 statistical software (Minitab, State College, PA, USA)
by employing the ManneWhitney nonparametric conﬁ-
dence interval (CI) testing method. All comparisons were
conducted for 20 pulse cycles at the 95% CI.
In order to compare and validate the results with other
studies from the literature, the following derived parame-
ters were calculated: pulsatile arterial energy loss (PAEL),
PWV, and wave reﬂection coefﬁcient (G).
PAEL
The DPeDD curve of the perfusion model exhibits a hys-
teresis effect similar to the in vivo measurements of
Sonesson et al. and Stefanadis et al.20,22 This area within
the aortic loop represents the PAEL.22 The calculated PAEL
for the unstented perfusion model, at the suprarenal loca-
tion, was 3.5 mm/mmHg. This was within the descending
aortic range of 3.16 to 14.10 mm/mmHg22
PWV
The PWV was measured by monitoring the pressures and
diameters at the systolic and diastolic phases. These data
were used to estimate the local PWV by applying Equation
(3),23 as shown in Table 2 at the infrarenal location.
PWV ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A
r
DP
DA
s
(3)
Where, A is the diastolic cross-sectional area, DA is the
difference between systolic and diastolic areas, DP is the
difference between systolic and diastolic pressures, and r is
the density of the ﬂuid.
Wave reﬂections
The wave reﬂections generated within the infrarenal
perfusion model, before and after stenting, were computed
by Equation (4) (Table 2).19 This equation calculates the
proportion of the pressure waveform being reﬂected, and is
given by the reﬂection coefﬁcient (G),
G ¼
AU
cU
 AScS
AU
cU
þ AScS
(4)
Where AU is the cross-sectional area upstream from the
proximal side; AS is the cross-sectional area at the locationof the proximal side, cU is the PVW upstream from the
proximal side, and cS is the PVW at the location of the
proximal side.
RESULTS
Device deformation characteristics
The curves describing circumferential loading cycles and
device deformation behaviour are shown in Fig. 3. The
length of the stent in contact with the strip divided the
circumferential load (Table 2), which presents the magni-
tudes of the radial resistive and COFs expressed in N/cm, for
all ﬁve devices at the diastolic diameter of the aorta
perfusion model. The Zenith and EndurantII devices had the
highest RRF (up to 3 N/cm), while the Fortron device had
the lowest magnitude of 0.11 N/cm. In the second half of
the cycle, the Zenith devices had the highest COF of up to
0.68 N/cm, while the Fortron and MFM had the lowest
magnitude of 0.03 N/cm and 0.06 N/cm, respectively. The
MFM had the greatest discrepancy of 14-fold between the
COF and RRF.Arterial wall/device interface compliance
Figs. 4 and 5 show the DPeDD curves for the stented
perfusion model at the supra- and infrarenal locations,
respectively. Equation (2) was applied to ﬁnd the C based
on these DPeDD curves, as shown in Figs. 4 and 5. Table 2
shows the median and interquartile range and the per-
centage median C variations when compared with the
unstented C, based on the 95% ManneWhitney CI test. At
the suprarenal region, all devices, except the Excluder,
signiﬁcantly decreased the compliance by 10e21%
(p < .002). At the infrarenal region, EndurantII and Excluder
signiﬁcantly decreased the compliance by 9e11%
(p < .001), while the MFM, Zenith, and Fortron did not
signiﬁcantly (p < .057) inﬂuence C. At the infrarenal region,
the MFM did not signiﬁcantly alter PAEL (median 2.3 mmHg
[p ¼ .903]), while the other devices increased the PAEL by
13e44% (p < .006) (Table 2).Stented perfusion model pulse wave analysis
The PWV of the unstented infrarenal section had a median
value of 10.6 m/s, which was in agreement with the post-
operative ﬁndings of Paraskevas et al.,24 who, post-
operatively, measured the mean aortic PWVs of
7.84  1.85 m/s and 10.08  1.57 m/s within AAA cases.
The PWV ranged from 10.9 m/s (MFM, p ¼ .164) to 15.1 m/
s (EndurantII, p < .001) for all devices tested (see Table 2).
High PWVs were recorded for the EndurantII (15.1 m/s;
p < .001) and Excluder (14.9 m/s; p < .001) devices. The
Zenith, Fortron, and MFM devices recorded the lowest PWV
measurements, with values of 11.1 m/s (p < .001), 10.8 m/s
(p ¼ .036), and 10.9 m/s (p ¼ .164), respectively.
For the unstented infrarenal perfusion model, G had a
median value of 7.6%, owing to the tapering vessel and
decreased compliance across the suprarenal and infrarenal
regions. The G was increased by 205e212% (p < .001) for
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 53the EndurantII and Excluder devices, and by 8e17%
(p < .001) for the MFM, Fortron, and Zenith devices.DISCUSSION
This study assessed the deformation characteristics and the
inﬂuence on the radial arterial compliance of ﬁve devices
for the treatment of AAAs, within a patient-speciﬁc perfu-
sion model.
The AAA model had an infrarenal neck angle of 57,
which falls within the IFU recommendations for four devices
(not the MFM). The Zenith, Excluder, and Fortron devices
can be used if the minimum neck length is 15 mm and the
infrarenal neck angle is <60, while the EndurantII can be
used if the infrarenal neck angle is <75, for the same
minimum neck length of 15 mm. The IFU of the MFM do not
specify a threshold for the infrarenal neck angulation. The
different device lengths were a result of limited access to a
wider range of devices, but they did comply with the IFU
and did not alter the measurements. There was a maximum
of 7% variation in the maximum proximal diameter be-
tween the devices (Table 1), which was unavoidable as the
preferred intended for use aortic diameters, as documented
by the manufacturers, were within the aorta’s infrarenal
diameter range.
Increased pulse wave velocity25 and low radial force can
affect stent ﬁxation leading to migration,26 while a high
radial force promotes continued dilation leading to migra-
tion, Type I endoleak.27 Previous studies applied point loads
on stents to assess the radial force.28 The problem with this
method is that stents do not experience point loads in vivo.
Another approach has externally compressed stent/de-
vices,29 and this study found the stents/SGs to deform
asymmetrically with hysteresis during the loading and
unloading cycles. Johnston et al. concluded that no usable
relationship between pressure and area reduction could be
determined as a result of this asymmetrical deformation.29
We applied an axisymmetric loading. The advantage of this
approach is the realistic response of the stent, which pro-
vides quantiﬁable results.29 Duda et al. obtained the radial
resistive and chronic outward circumferential forces for four
8-mm diameter uncovered self-expanding stents,14
observing similar behaviour during loading/unloading, as
was found in this study (Fig. 3).
The Excluder and EndurantII devices signiﬁcantly
decreased C when compared with the unstented perfusion
model, as it can be seen in Fig. 5 and Table 2. This resulted
in a decreased compliance of 18e23% and 14e25% for the
suprarenal and infrarenal regions, respectively. MFM,
Zenith, and Fortron had a reduced compliance of 11e14%
and 1e7% for the suprarenal and infrarenal regions,
respectively. These differences in compliance between de-
vices may not be associated with the different elastic
properties of the fabrics. Although the measured compli-
ance of Dacron (woven polyester) and expanded poly-
tetraﬂuoroethylene (ePTFE) grafts, used for vascular
reconstruction,30 showed that the Dacron has a higher
compliance value (1.8  1.2% per mmHg  102) thanePTFE (1.2  0.3% per mmHg  102), these materials
come with different textile structure of the woven design in
an endograft, which may affect their behaviour. Moreover,
the diameter of the woven polyester for EndurantII and
ePTFE for Excluder is in a relaxed state, when the oversized
device is stressed in the arterial wall.
The PAEL within the infrarenal region was increased by
the presence of the devices (Table 2; Fig. 5). This increase in
PAEL may result in decreased distal perfusion, increased
pressure wave reﬂections, and increased pulsatile me-
chanical stress at the interface between the noncompliant
stented vessels and the native artery.5,6 The elasticity of the
arterial wall is responsible for the existence of wave re-
ﬂections. The propagating pressure or ﬂow waveforms will
be reﬂected if the wave encounters any change in calibre
along the arterial wall, such as a variation in cross-sectional
area or material properties as given by Equation (4).19 This
variation in arterial calibre occurred after the insertion for
all ﬁve devices, with varying degrees of severity. The early
arrival of a reﬂected wave increases left ventricular load,
which affects both ventricular emptying and driving pres-
sure for coronary perfusion,19,31 which eventually leads to
low cardiac output, impaired coronary perfusion, heart
failure, hypertension, and shock.19,32 The G measurements
that offer superiority to one device over another may
characterise the situations of highly angulated AAA necks,
as it is the case in this study, which has not yet been re-
ported. Therefore, caution should be taken when inter-
preting these results.
This study found differences between the devices’ per-
formance. These differences arise mainly from the unique
combination of material properties for the fabric and stent in
each device (Table 1), and partly from the stent struts con-
ﬁgurations. Three devices have a Z stent design (EndurantII,
Zenith, and Excluder), one device has a proximal diamond
stent design (Fortron), and one device has a braided mesh
design (MFM). The stent design of the latter two devices
produced the smallest radial forces among all tested devices
as showed in Table 2. This fact may suggest that similar stent
designs may be suitable towards achieving the right balance
for future devices, between compliant device behaviour and
ﬁxation radial force, which would prevent proximal migration
without stiffening the arterial wall.
The patient-speciﬁc perfusion model was chosen to
recreate, as closely as possible, an example of real-life
geometrical constraints, in which the devices have to
perform. The ILT did not affect the compliance measure-
ments, but it was replicated as part of a complex perfusion
model. Part of the aim of this study was to predict how
these devices may behave in real patients. Further studies
may be carried out regarding the inﬂuence of anatomy over
the device performance, where straight cylindrical models
can be used for performance comparison.Study limitations
Two limitations to the circumferential loading test approach
are the unknown friction effects and local impingement of
54 L. Morris et al.the stent against the roller and base. With the circumfer-
ential loaded test, employing a combination of two rollers
eliminated the local impingement effects. The ﬁlm used,
Tyvek (DuPont), has a low coefﬁcient of friction.
We assumed a homogenous and isotropic silicone wall,
which is in contact with the device wall, thus creating a
composite material. That assumption allowed the use of
Equation (2) for calculating wall compliance because the
fabric of the SGs was not fully stretched after deployment,
and the devices struts’ strain within the DP was low. The
relative movement between the stent struts and the aortic
wall was not monitored. The PAEL parameter was assessed,
only at the infrarenal neck, and not at the devices limbs,
therefore it may not provide a strong relation with a po-
tential cardiac risk.CONCLUSION
The commercially available EVAR devices lower the arterial
wall compliance at the stent/arterial wall interface after
implantation. The Excluder device was found to be the most
compliant in the suprarenal region, as this was the only
tested device with no suprarenal ﬁxation stent. The MFM
was found to be the most compliant in the stented supra-
renal region, while the Fortron device was the most
compliant in the stented infrarenal region. From a clinical
perspective, device selection based on minimum inﬂuence
on the radial arterial compliance is advised, in order to
prevent long-term device related complications. Future
studies should analyse a wider range of commercially
available devices to identify those that would pertain for
low or zero complications rate.CONFLICT OF INTEREST
None.FUNDING
None.APPENDIX A. SUPPLEMENTARY DATA
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.ejvs.2015.07.041.REFERENCES
1 Beebe HG, Cronenwett JL, Katzen BT, Brewster DC, Green RM.
Vanguard Endograft Trial Investigators. Results of an aortic
endograft trial: impact of device failure beyond 12 months.
J Vasc Surg 2001;33:S55e63.
2 Morris L, Stefanov F, McGloughlin T. Stent graft performance in
the treatment of abdominal aortic aneurysms: the inﬂuence of
compliance and geometry. J Biomech 2013;46:383e95.
3 Bryce Y, Rogoff P, Romanelli D, Reichle R. Endovascular repair of
abdominal aortic aneurysms: vascular anatomy, device selec-
tion, procedure, and procedure-speciﬁc complications. Radio-
graphics 2015;35:593e615.
4 Humphery JD, Na S. Elastodynamics and arterial wall stress.
Ann Biomed Eng 2002;30:509e23.5 Tortoriello A, Pedrizzetti G. Flow-tissue interaction with
compliance mismatch in a model stented artery. J Biomech
2004;37:1e11.
6 Back M, Kopchok G, Mueller M, Cavaye D, Donayre C,
White RA. Changes in arterial wall compliance after endovas-
cular stenting. J Vasc Surg 1994;19:905e11.
7 Vernhet H, Demaria R, Juan JM, Oliva-Lauraire MC, Sénac JP,
Dauzat M. Changes in wall mechanics after endovascular
stenting in the rabbit aorta: comparison of three stent designs.
Am J Roentgenol 2001;176:803e7.
8 Ene F, Delassus P, Morris L. The inﬂuence of computational
assumptions on analysing abdominal aortic aneurysm haemo-
dynamics. Proc Inst Mech Eng H 2014;228:768e80.
9 Pihkala J, Thyagarajan GK, Taylor GP, Nykanen D, Benson LN. The
effect of implantation of aortic stents on compliance and blood
ﬂowanexperimental study in pigs.Cardiol Young2001;11:173e81.
10 Brugaletta S, Gogas BD, Garcia-Garcia HM, Faroog V, Girasis C,
Heo JH, et al. Vascular compliance change of the coronary
vessel wall after bioresorbable vascular scaffold implantation in
the treated and adjacent segments. Circ J 2012;76:1616e23.
11 Cheng CP, Parker D, Taylor CA. Quantiﬁcation of wall shear
stress in large blood vessels using Lagrangian interpolation
functions with cine phase-contrast magnetic resonance imag-
ing. Ann Biomed Eng 2002;30:1020e32.
12 Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of
cardiovascular events and all-cause mortality with arterial
stiffness: a systematic review and meta-analysis. J Am Coll
Cardiol 2010;55:1318e27.
13 Duerig TW, Pelton AR, Stoeckel D. The utility of superelasticity
in medicine. Biomed Mater Eng 1996;6(4):255e66.
14 Duda SH,Wiskirchen J, Tepe G, Blitzer M, Kaulich TW, Stoeckel D,
et al. Physical properties of endovascular stents: an experi-
mental comparison. J Vasc Interv Radiol 2000;11:645e54.
15 Ene F, Gachon C, Delassus P, Carroll R, Stefanov F, O’Flynn P,
et al. In vitro evaluation of the effects of intraluminal thrombus
on abdominal aortic aneurysm wall dynamics. Med Eng Phys
2011;33:957e66.
16 Morris L, O’Donnell P, Delassus P, McGloughlin T. Experimental
assessment of stress patterns in abdominal aortic aneurysms
using the photoelastic method. Strain 2004;40:165e72.
17 Raghavan ML, Webster MW, Vorp DA. Ex vivo biomechanical
behavior of abdominal aortic aneurysm: assessment using a
new mathematical model. Ann Biomed Eng 1996;24:573e82.
18 Wang DH, Makaroun M, Webster MW, Vorp DA. Mechanical
properties and microstructure of intraluminal thrombus from
abdominal aortic aneurysm. J Biomech Eng 2001;123:536e9.
19 Nichols WW, O’Rourke MF. McDonald’s blood ﬂow in arteries:
theoretical, experimental and clinical principles. Chapter 9:
Contours of pressure and ﬂow waves in arteries. 5th edn.
London: Hodder Arnold; 2005. p. 165e91.
20 Sonesson B, Länne T, Vernersson E, Hansen F. Sex difference in
the mechanical properties of the abdominal aorta in human
beings. J Vasc Surg 1994;20:959e69.
21 Vorp DA, Mandarino WA, Webster MW, Gorcsan 3rd J. Po-
tential inﬂuence of intraluminal thrombus on abdominal aortic
aneurysm as assessed by a new non-invasive method. Car-
diovasc Surg 1996;4:732e9.
22 Stefanadis C, Dernellis J, Vlachopoulos C, Tsiouﬁs C, Tsiamis E,
Toutouzas K, et al. Aortic function in arterial hypertension
determined by pressure-diameter relation: effects of diltiazem.
Circulation 1997;96:1853e8.
23 Wylie EB, Streeter VL. Fluid transients. New York: McGraw-Hill
Book Co.; 1978.
Experimental Evaluation of Device/Arterial Wall Compliance Mismatch 5524 Paraskevas KI, Bessias N, Psathas C, Akridas K, Nikitas G,
Andrikopoulos V, et al. Evaluation of aortic stiffness (aortic
pulseewave velocity) before and after elective abdominal
aortic aneurysm repair procedures: a pilot study. Open Car-
diovasc Med J 2009;3:173e5.
25 Tzilalis VD, Kamvysis D, Panagou P, Kaskarelis I, Lazarides MK,
Perdikides T, et al. Increased pulse wave velocity and arterial
hypertension in young patients with thoracic aortic endografts.
Ann Vasc Surg 2012;26:462e7.
26 Moore JE, Berry JL. Fluid and solid mechanical implications of
vascular stenting. Ann Biomed Eng 2002;30:498e508.
27 Mattes J, Chemelli A, Wick M, Soimu D, Pontow C, Lopez A,
et al. Evaluation of a new computerized analysis system
developed for the processing of CT follow-up scans after EVR of
infrarenal aneuysm. Eur J Radiol 2012;81:496e501.
28 Flueckiger F, Sternthal H, Klein GE, Aschauer M, Szolar D,
Kleinhappl G. Strength, elasticity, and plasticity of expandable* Corresponding author.
E-mail address: spanos.kon@gmail.com (K. Spanos).
1078-5884/ 2015 European Society for Vascular Surgery. Published by Else
http://dx.doi.org/10.1016/j.ejvs.2015.10.006metal stents: in vitro studies with three types of stress. J Vasc
Interv Radiol 1994;5:745e50.
29 Johnston CR, Lee K, Flewitt J, Moore R, Dobson GM,
Thornton GM. The mechanical properties of endovascular
stents: an in vitro assessment. Cardiovasc Eng 2010;10:
128e35.
30 Tai NR, Salacinski HJ, Edwards A, Hamilton G, Seifalian AM.
Compliance properties of conduits used in vascular recon-
struction. Br J Surg 2000;87:1516e24.
31 Zannoli R, Schiereck P, Celletti F, Branzi A, Magnani B. Effects of
wave reﬂection timing on left ventricular mechanics. J Biomech
1999;32:249e54.
32 Ikonomidis I, Lekakis J, Papadopoulos C, Triantafyllidi H,
Paraskevaidis I, Georgoula G, et al. Incremental value of pulse
wave velocity in the determination of coronary microcircula-
tory dysfunction in never-treated patients with essential hy-
pertension. Am J Hypertens 2008;21:806e13.Eur J Vasc Endovasc Surg (2016) 51, 55COUP D’OEIL
Endovascular Treatment of Double Hepatic Arterial Aneurysm
K. Spanos *, A.D. Giannoukas
Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, GreeceA 62 year old male presented with atypical right subcostal pain. Abdominal ultrasound showed an intra-hepatic arterial
aneurysm while CT angiography of aorta and branch arteries also detected an additional aneurysm at the mid-portion of
hepatic artery (yellow arrows). Endovascular treatment was undertaken ﬁrstly with coil embolization of the feeding branch
of the intra-hepatic aneurysm coming off the right branch of hepatic artery proper followed by placement of a 6  50 mm
covered stent (Viabahn, Gore; red arrows) proximally. Completion angiography conﬁrmed the exclusion of both aneurysms
and the patient was discharged the next day on dual antiplatelet therapy (clopidogrel 75 mg, aspirin 100 mg).vier Ltd. All rights reserved.
